• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤与年龄及性别的相关性发病情况。

Age-related and gender-related occurrence of pituitary adenomas.

作者信息

Mindermann T, Wilson C B

机构信息

Department of Neurological Surgery, School of Medicine, University of California, San Francisco.

出版信息

Clin Endocrinol (Oxf). 1994 Sep;41(3):359-64. doi: 10.1111/j.1365-2265.1994.tb02557.x.

DOI:10.1111/j.1365-2265.1994.tb02557.x
PMID:7893282
Abstract

OBJECTIVE

To evaluate the various types of pituitary adenomas according to sex and age group. Few studies have attempted such an analysis, and most have focused on specific age groups, especially children. Recent data suggest that the frequency of different types of pituitary adenomas varies according to age and sex.

DESIGN

A retrospective review of the records of 2230 patients who underwent surgery for a pituitary adenoma at the University of California, San Francisco (UCSF), between January 1969 and June 1993.

METHODS

The distribution of tumours was analysed according to age at surgery, sex, and the clinical phenotype of the tumour. Age groups were defined as the decades of life.

RESULTS

Prolactinomas were the most common tumours (39%), followed by endocrine-inactive adenomas, growth-hormone-releasing adenomas, and adrenocorticotrophic hormone-releasing adenomas causing Cushing's disease; ACTH-releasing adenomas causing Nelson's syndrome and thyrotrophin (TSH)-releasing adenomas were rare. The female-to-male ratio differed considerably between the various adenoma types and between age groups. Prolactinomas, ACTH-releasing adenomas, and TSH-releasing adenomas occurred mostly in females; endocrine-inactive and GH-releasing adenomas occurred mostly in males. In older age groups, all adenoma types, except for endocrine-inactive adenomas, tended to assume a more balanced gender distribution. Among patients with prolactinomas, endocrine-inactive, ACTH-releasing, and to a lesser extent GH-releasing adenomas, the greatest discrepancy in gender distribution seemed to coincide with the peak occurrence of each tumour type. The peak occurrence was from the second to the fifth decade of life for prolactinomas and from the fourth to the eighth decade for endocrine-inactive adenomas. GH-releasing, ACTH-releasing, and TSH-releasing adenomas were more evenly distributed throughout the adult life span.

CONCLUSIONS

The frequency of pituitary adenomas varies greatly according to age and sex. The various adenoma types have their peak occurrence in distinctly different age groups and differ greatly in their female-to-male ratios. The female-to-male ratio for a given adenoma type varies greatly with age.

摘要

目的

根据性别和年龄组评估各类垂体腺瘤。很少有研究尝试进行这样的分析,且大多数研究聚焦于特定年龄组,尤其是儿童。近期数据表明,不同类型垂体腺瘤的发生率随年龄和性别而变化。

设计

对1969年1月至1993年6月期间在加利福尼亚大学旧金山分校(UCSF)接受垂体腺瘤手术的2230例患者的记录进行回顾性研究。

方法

根据手术时的年龄、性别和肿瘤的临床表型分析肿瘤的分布情况。年龄组按十年划分。

结果

泌乳素瘤是最常见的肿瘤(39%),其次是无内分泌活性腺瘤、生长激素释放腺瘤以及导致库欣病的促肾上腺皮质激素释放腺瘤;导致尼尔森综合征的促肾上腺皮质激素释放腺瘤和促甲状腺激素(TSH)释放腺瘤较为罕见。不同腺瘤类型以及不同年龄组的男女比例差异很大。泌乳素瘤、促肾上腺皮质激素释放腺瘤和促甲状腺激素释放腺瘤大多发生于女性;无内分泌活性腺瘤和生长激素释放腺瘤大多发生于男性。在老年组中,除无内分泌活性腺瘤外,所有腺瘤类型的性别分布趋于更为均衡。在泌乳素瘤、无内分泌活性腺瘤、促肾上腺皮质激素释放腺瘤以及程度较轻的生长激素释放腺瘤患者中,性别分布的最大差异似乎与每种肿瘤类型的发病高峰一致。泌乳素瘤的发病高峰在生命的第二个至第五个十年,无内分泌活性腺瘤的发病高峰在第四个至第八个十年。生长激素释放腺瘤、促肾上腺皮质激素释放腺瘤和促甲状腺激素释放腺瘤在成年期分布更为均匀。

结论

垂体腺瘤的发生率随年龄和性别有很大差异。不同腺瘤类型在明显不同的年龄组达到发病高峰,且男女比例差异很大。特定腺瘤类型的男女比例随年龄变化很大。

相似文献

1
Age-related and gender-related occurrence of pituitary adenomas.垂体腺瘤与年龄及性别的相关性发病情况。
Clin Endocrinol (Oxf). 1994 Sep;41(3):359-64. doi: 10.1111/j.1365-2265.1994.tb02557.x.
2
Pediatric pituitary adenomas.
Neurosurgery. 1995 Feb;36(2):259-68; discussion 269. doi: 10.1227/00006123-199502000-00004.
3
Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.人垂体腺瘤中胃饥饿素及生长激素(GH)促分泌素受体(GHSR)mRNA的表达
Clin Endocrinol (Oxf). 2001 Jun;54(6):759-68. doi: 10.1046/j.1365-2265.2001.01286.x.
4
The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.促甲状腺激素释放激素受体1信使核糖核酸在人垂体腺瘤中的表达
Clin Endocrinol (Oxf). 2001 Mar;54(3):309-16. doi: 10.1046/j.1365-2265.2001.01237.x.
5
Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.库欣病和纳尔逊综合征中高分化及未分化促肾上腺皮质激素分泌腺瘤的电子显微镜形态计量学研究
Virchows Arch A Pathol Anat Histopathol. 1991;419(5):395-401. doi: 10.1007/BF01605073.
6
Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?库欣病患者生长激素和催乳素对促肾上腺皮质激素释放激素的反应:腺瘤性促肾上腺皮质细胞的旁分泌作用?
Clin Endocrinol (Oxf). 1998 Oct;49(4):433-9. doi: 10.1046/j.1365-2265.1998.00531.x.
7
Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.培养的促肾上腺皮质激素-催乳素混合垂体腺瘤细胞的催乳素分泌。
Acta Endocrinol (Copenh). 1985 Apr;108(4):456-63. doi: 10.1530/acta.0.1080456.
8
Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.采用逆转录聚合酶链反应法检测人垂体腺瘤中Pit-1基因的表达。
Clin Endocrinol (Oxf). 1996 Sep;45(3):263-72. doi: 10.1046/j.1365-2265.1996.00812.x.
9
Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.中国某单一中心的 1 型多发性内分泌肿瘤患者的垂体腺瘤:单中心经验。
Pituitary. 2019 Apr;22(2):113-123. doi: 10.1007/s11102-019-00939-x.
10
The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.2001-2011 年期间瑞典西部垂体腺瘤的发病率。
Eur J Endocrinol. 2014 Oct;171(4):519-26. doi: 10.1530/EJE-14-0144. Epub 2014 Aug 1.

引用本文的文献

1
Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study.卡麦角林治疗男性微小泌乳素瘤的疗效、性腺轴恢复及停药结局:一项回顾性队列研究
Endocrine. 2025 Apr 9. doi: 10.1007/s12020-025-04215-w.
2
X-linked ubiquitin-specific peptidase 11 (USP11) increases susceptibility to Cushing's disease in women.X连锁泛素特异性肽酶11(USP11)增加女性患库欣病的易感性。
Acta Neuropathol Commun. 2025 Feb 5;13(1):22. doi: 10.1186/s40478-025-01938-9.
3
Long-term tumor control following repeat gamma-knife radiosurgery of growing pituitary adenomas: a population-based cohort study.
生长型垂体腺瘤重复伽玛刀放射外科治疗后的长期肿瘤控制:一项基于人群的队列研究。
Acta Neurochir (Wien). 2024 Dec 6;166(1):494. doi: 10.1007/s00701-024-06341-2.
4
Assessment of the initial results of pituitary tumor registry at a tertiary hospital of Iran: 2009-2022.伊朗一家三级医院垂体肿瘤登记处2009 - 2022年初始结果评估
J Diabetes Metab Disord. 2024 Aug 9;23(2):2143-2149. doi: 10.1007/s40200-024-01481-9. eCollection 2024 Dec.
5
Variable anatomical features of acromegaly in the nasal cavity and paranasal sinuses: implications for endoscopic endonasal transsphenoidal surgery.肢端肥大症鼻腔和鼻窦的解剖学特征:经鼻内镜经蝶窦手术的意义。
Acta Neurochir (Wien). 2024 Oct 15;166(1):408. doi: 10.1007/s00701-024-06307-4.
6
Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review.催乳素瘤青少年患者早期手术治疗的可行性:病例报告及文献复习。
Medicina (Kaunas). 2024 Aug 19;60(8):1345. doi: 10.3390/medicina60081345.
7
Dysregulated zinc homeostasis and microadenomas in the anterior pituitary: pathological insights into suicide risk.垂体前叶锌稳态失调与微腺瘤:对自杀风险的病理学见解
Front Psychiatry. 2024 Aug 13;15:1446255. doi: 10.3389/fpsyt.2024.1446255. eCollection 2024.
8
Pituitary apoplexy as a mimicker of infectious meningitis in an adolescent female patient.垂体卒中在一名青春期女性患者中表现为感染性脑膜炎的模仿者。
Ann Intern Med Clin Cases. 2023 Sep;2(9). doi: 10.7326/aimcc.2022.1328. Epub 2023 Sep 5.
9
Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease.经鼻内镜手术治疗泌乳素瘤:疾病控制的预测因素和持续性疾病的处理。
Neurosurg Rev. 2023 Nov 9;46(1):295. doi: 10.1007/s10143-023-02199-7.
10
Influence of gender and sexual hormones on outcomes after pituitary surgery: a systematic review and meta-analysis.性别和性激素对垂体手术后结局的影响:系统评价和荟萃分析。
Acta Neurochir (Wien). 2023 Sep;165(9):2445-2460. doi: 10.1007/s00701-023-05726-z. Epub 2023 Aug 9.